JelikaLite Corp

A neuromodulation platform: non-invasive brain stimulation medical device with AI personalization, improving autistic children's speech and socialization.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location New York, NY, USA
  • Currency USD
  • Founded February 2019
  • Employees 4
  • Incorporation Type C-corp
  • Website jelikalite.com

Company Summary

Autism rates keep rising worldwide, the costs are skyrocketing, yet there are no FDA approved treatments that target its core symptoms. JelikaLite is developing Cognilum -– a neuromodulation platform combining non-invasive wearable brain stimulation medical device with ML personalization, rapidly improving children's speech and socialization. Our vision is to provide effective treatment to children affected by neurological disorders worldwide.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free